Columbus Macro, LLC Biogen Inc. Transaction History

Columbus Macro, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Jan 27, 2020	SELL	$220.06 - $304.07 $334,491 - $462,186	-1,520 Closed	0 $0
Q3 2019 Oct 22, 2019	SELL	$217.44 - $243.88 $61,318 - $68,774	-282 Reduced 15.65%	1,520 $354,000
Q2 2019 Jul 16, 2019	BUY	$219.29 - $241.72 $11,403 - $12,569	52 Added 2.97%	1,802 $421,000
Q1 2019 Apr 22, 2019	SELL	$216.71 - $338.96 $10,185 - $15,931	-47 Reduced 2.62%	1,750 $414,000
Q4 2018 Jan 14, 2019	SELL	$278.5 - $352.75 $22,558 - $28,572	-81 Reduced 4.31%	1,797 $541,000
Q3 2018 Oct 12, 2018	BUY	$293.51 - $383.83 $16,143 - $21,110	55 Added 3.02%	1,878 $664,000
Q2 2018 Jul 19, 2018	SELL	$257.52 - $306.91 $12,876 - $15,345	-50 Reduced 2.67%	1,823 $529,000
Q1 2018 Apr 17, 2018	BUY	$260.13 - $367.91 $487,223 - $689,095	1,873 New	1,873 $513,000

990

131M

1.12M

1.43M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $20.4B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Columbus Macro, LLC, based on Form 13F filings with the SEC.

Stay updated on Columbus Macro, LLC with notifications on news.